Nutex Health (NUTX) Net Income towards Common Stockholders (2010 - 2026)

Nutex Health has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting $62.8 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $62.8 million, up 319.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.3 million (up 73.48% YoY), and the FY2025 annual result was $180.4 million, up 245.65% from the prior year.
• Net Income towards Common Stockholders came in at $62.8 million for Q1 2026 at Nutex Health, up from $16.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $100.0 million in Q4 2024 to a low of -$422.5 million in Q3 2022.
• The 5-year median for Net Income towards Common Stockholders is $3.0 million (2024), against an average of -$9.7 million.
• Across the five-year window, Net Income towards Common Stockholders slumped 885.45% in 2022 and soared 4210.71% in 2025, its largest moves.
• Nutex Health's Net Income towards Common Stockholders stood at $9.9 million in 2022, then slumped by 379.08% to -$27.7 million in 2023, then soared by 461.03% to $100.0 million in 2024, then sank by 83.4% to $16.6 million in 2025, then surged by 277.91% to $62.8 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $62.8 million (Q1 2026), $16.6 million (Q4 2025), and $96.8 million (Q3 2025), per Business Quant data.